H.R. 620, Alzheimer’s Accountability and Investment Act
As reported by the House Committee on Energy and Commerce on May 31, 2024
By Fiscal Year, Millions of Dollars
2024
2024-2029
2024-2034
Direct Spending (Outlays)
0
0
0
Revenues
0
0
0
Increase or Decrease (-) in the Deficit
0
0
0
Spending Subject to Appropriation (Outlays)
0
0
0
Increases net direct spending in any of the four consecutive 10-year periods beginning in 2035?
No
Statutory pay-as-you-go procedures apply?
No
Mandate Effects
Increases on-budget deficits in any of the four consecutive 10-year periods beginning in 2035?
No
Contains intergovernmental mandate?
No
Contains private-sector mandate?
No
Summary
H.R 620 would require the National Institutes of Health to prepare annual estimates of the costs of research conducted under the National Alzheimer’s Project Act. Those estimates would be submitted to the President for review and transmittal to the Congress. Because the agency already provides such information, CBO estimates that implementing H.R. 620 would have no additional effect on the federal budget.
